During the past decade, Memorial Sloan Kettering Nassau (Limited Protocol Activities) conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 2 clinical trials were completed, i.e. on average, 3.2% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 2 clinical trials were completed. i.e. 4.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan Kettering Nassau (Limited Protocol Activities)" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Dana-Farber Cancer Institute" with 3 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Nassau (Limited Protocol Activities)" are "Breast Cancer" (7 trials), "Multiple Myeloma" (4 trials), "Prostate Cancer" (4 trials), "Lung Cancer" (3 trials) and "Solid Tumor" (3 trials). Many other conditions were trialed in "Memorial Sloan Kettering Nassau (Limited Protocol Activities)" in a lesser frequency.

Most popular intervention types in "Memorial Sloan Kettering Nassau (Limited Protocol Activities)" are "Drug" (45 trials), "Other" (11 trials), "Radiation" (11 trials), "Procedure" (7 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (8 trials), "Gemcitabine" (5 trials), "Nivolumab" (4 trials), "Carboplatin" (3 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan Kettering Nassau (Limited Protocol Activities)" are 52 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Sloan Kettering Nassau (Limited Protocol Activities)". undefined are not yet recruiting, 48 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Memorial Sloan Kettering Nassau (Limited Protocol Activities), undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan Kettering Nassau (Limited Protocol Activities), 15 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".